Innovation
32 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 1,460 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 14 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 13 |
| 2026 | 2 |
Social engagement
Social engagement: 3.4K social following, 3 posts in the last 12 months — above the industry median.
Investor mix
11 investors on record; lead investors include Monashee Investment Management, Hercules Capital, Mount Sinai, Arch Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 1 | 9% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 6 | 55% |
Recent activity
21 May 2026
Event
2026 ASCO Annual Meeting
14 Apr 2026
Event
AACR Annual Meeting 2026
6 Nov 2025
Partnership
AVEO Oncology
